These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19760628)

  • 1. p53 is dispensable for the induction of apoptosis after inhibition of protein kinase CK2.
    Schneider CC; Hessenauer A; Montenarh M; Götz C
    Prostate; 2010 Feb; 70(2):126-34. PubMed ID: 19760628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CK2 inhibition induces apoptosis via the ER stress response.
    Hessenauer A; Schneider CC; Götz C; Montenarh M
    Cell Signal; 2011 Jan; 23(1):145-51. PubMed ID: 20807566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R; Bedi A
    Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of CK2 activity provokes different responses in hormone-sensitive and hormone-refractory prostate cancer cells.
    Hessenauer A; Montenarh M; Götz C
    Int J Oncol; 2003 Jun; 22(6):1263-70. PubMed ID: 12738992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular hydrogen peroxide production is an upstream event in apoptosis induced by down-regulation of casein kinase 2 in prostate cancer cells.
    Ahmad KA; Wang G; Ahmed K
    Mol Cancer Res; 2006 May; 4(5):331-8. PubMed ID: 16687488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Casein kinase 2 inhibition decreases hypoxia-inducible factor-1 activity under hypoxia through elevated p53 protein level.
    Hubert A; Paris S; Piret JP; Ninane N; Raes M; Michiels C
    J Cell Sci; 2006 Aug; 119(Pt 16):3351-62. PubMed ID: 16882692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resorufin: a lead for a new protein kinase CK2 inhibitor.
    Sandholt IS; Olsen BB; Guerra B; Issinger OG
    Anticancer Drugs; 2009 Apr; 20(4):238-48. PubMed ID: 19177021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines.
    Watanabe J; Nishiyama H; Matsui Y; Ito M; Kawanishi H; Kamoto T; Ogawa O
    Oncogene; 2006 Apr; 25(17):2500-8. PubMed ID: 16518417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Casein kinase 2 inhibition attenuates androgen receptor function and cell proliferation in prostate cancer cells.
    Yao K; Youn H; Gao X; Huang B; Zhou F; Li B; Han H
    Prostate; 2012 Sep; 72(13):1423-30. PubMed ID: 22290244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Casein kinase II inhibition induces apoptosis in pancreatic cancer cells.
    Hamacher R; Saur D; Fritsch R; Reichert M; Schmid RM; Schneider G
    Oncol Rep; 2007 Sep; 18(3):695-701. PubMed ID: 17671722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time schedule-dependent effect of the CK2 inhibitor TBB on PC-3 human prostate cancer cell viability.
    Orzechowska E; Kozłowska E; Staroń K; Trzcińska-Danielewicz J
    Oncol Rep; 2012 Jan; 27(1):281-5. PubMed ID: 21993828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
    Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
    Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2.
    Pagano MA; Meggio F; Ruzzene M; Andrzejewska M; Kazimierczuk Z; Pinna LA
    Biochem Biophys Res Commun; 2004 Sep; 321(4):1040-4. PubMed ID: 15358133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53-dependent inhibition of mammalian cell survival by a genetically selected peptide aptamer that targets the regulatory subunit of protein kinase CK2.
    Martel V; Filhol O; Colas P; Cochet C
    Oncogene; 2006 Nov; 25(56):7343-53. PubMed ID: 16751801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emodin induces apoptosis in human prostate cancer cell LNCaP.
    Yu CX; Zhang XQ; Kang LD; Zhang PJ; Chen WW; Liu WW; Liu QW; Zhang JY
    Asian J Androl; 2008 Jul; 10(4):625-34. PubMed ID: 18478162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of protein kinase CK2 leads to a modulation of androgen receptor dependent transcription in prostate cancer cells.
    Götz C; Bachmann C; Montenarh M
    Prostate; 2007 Feb; 67(2):125-34. PubMed ID: 17044081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA; Lupu R
    Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level.
    Di Maira G; Brustolon F; Bertacchini J; Tosoni K; Marmiroli S; Pinna LA; Ruzzene M
    Oncogene; 2007 Oct; 26(48):6915-26. PubMed ID: 17486073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of protein kinase CK2 protein subunits and p53 in F9 teratocarcinoma cells in the absence and presence of cisplatin.
    Küpper M; Köster M; Schmidt-Spaniol I; Wagner-Gillen I; Issinger OG
    Cell Mol Biol Res; 1994; 40(5-6):587-92. PubMed ID: 7735333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.